19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Machine-learning-derived classifier predicts absence of persistent pain after breast cancer surgery with high accuracy

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Prevention of persistent pain following breast cancer surgery, via early identification of patients at high risk, is a clinical need. Supervised machine-learning was used to identify parameters that predict persistence of significant pain.

          Methods

          Over 500 demographic, clinical and psychological parameters were acquired up to 6 months after surgery from 1,000 women (aged 28–75 years) who were treated for breast cancer. Pain was assessed using an 11-point numerical rating scale before surgery and at months 1, 6, 12, 24, and 36. The ratings at months 12, 24, and 36 were used to allocate patents to either “persisting pain” or “non-persisting pain” groups. Unsupervised machine learning was applied to map the parameters to these diagnoses.

          Results

          A symbolic rule-based classifier tool was created that comprised 21 single or aggregated parameters, including demographic features, psychological and pain-related parameters, forming a questionnaire with “yes/no” items (decision rules). If at least 10 of the 21 rules applied, persisting pain was predicted at a cross-validated accuracy of 86% and a negative predictive value of approximately 95%.

          Conclusions

          The present machine-learned analysis showed that, even with a large set of parameters acquired from a large cohort, early identification of these patients is only partly successful. This indicates that more parameters are needed for accurate prediction of persisting pain. However, with the current parameters it is possible, with a certainty of almost 95%, to exclude the possibility of persistent pain developing in a woman being treated for breast cancer.

          Electronic supplementary material

          The online version of this article (10.1007/s10549-018-4841-8) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references38

          • Record: found
          • Abstract: found
          • Article: not found

          Global estimates of cancer prevalence for 27 sites in the adult population in 2008.

          Recent estimates of global cancer incidence and survival were used to update previous figures of limited duration prevalence to the year 2008. The number of patients with cancer diagnosed between 2004 and 2008 who were still alive at the end of 2008 in the adult population is described by world region, country and the human development index. The 5-year global cancer prevalence is estimated to be 28.8 million in 2008. Close to half of the prevalence burden is in areas of very high human development that comprise only one-sixth of the world's population. Breast cancer continues to be the most prevalent cancer in the vast majority of countries globally; cervix cancer is the most prevalent cancer in much of Sub-Saharan Africa and Southern Asia and prostate cancer dominates in North America, Oceania and Northern and Western Europe. Stomach cancer is the most prevalent cancer in Eastern Asia (including China); oral cancer ranks as the most prevalent cancer in Indian men and Kaposi sarcoma has the highest 5-year prevalence among men in 11 countries in Sub-Saharan Africa. The methods used to estimate point prevalence appears to give reasonable results at the global level. The figures highlight the need for long-term care targeted at managing patients with certain very frequently diagnosed cancer forms. To be of greater relevance to cancer planning, the estimation of other time-based measures of global prevalence is warranted. Copyright © 2012 UICC.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Fear-avoidance model of chronic musculoskeletal pain: 12 years on.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              The association between chronic pain and obesity

              Obesity and pain present serious public health concerns in our society. Evidence strongly suggests that comorbid obesity is common in chronic pain conditions, and pain complaints are common in obese individuals. In this paper, we review the association between obesity and pain in the general population as well as chronic pain patients. We also review the relationship between obesity and pain response to noxious stimulation in animals and humans. Based upon the existing research, we present several potential mechanisms that may link the two phenomena, including mechanical/structural factors, chemical mediators, depression, sleep, and lifestyle. We discuss the clinical implications of obesity and pain, focusing on the effect of weight loss, both surgical and noninvasive, on pain. The literature suggests that the two conditions are significant comorbidities, adversely impacting each other. The nature of the relationship however is not likely to be direct, but many interacting factors appear to contribute. Weight loss for obese pain patients appears to be an important aspect of overall pain rehabilitation, although more efforts are needed to determine strategies to maintain long-term benefit.
                Bookmark

                Author and article information

                Contributors
                +49-69-6301-4589 , j.loetsch@em.uni-frankfurt.de
                Journal
                Breast Cancer Res Treat
                Breast Cancer Res. Treat
                Breast Cancer Research and Treatment
                Springer US (New York )
                0167-6806
                1573-7217
                6 June 2018
                6 June 2018
                2018
                : 171
                : 2
                : 399-411
                Affiliations
                [1 ]ISNI 0000 0004 1936 9721, GRID grid.7839.5, Institute of Clinical Pharmacology, , Goethe - University, ; Theodor – Stern - Kai 7, 60590 Frankfurt am Main, Germany
                [2 ]Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP, Theodor – Stern - Kai 7, 60596 Frankfurt am Main, Germany
                [3 ]ISNI 0000 0000 9950 5666, GRID grid.15485.3d, Pain Clinic, Department of Anaesthesiology, Intensive Care and Pain Medicine, , Helsinki University Hospital and University of Helsinki, ; Helsinki, Finland
                [4 ]ISNI 0000 0000 9950 5666, GRID grid.15485.3d, Breast Surgery Unit, Comprehensive Cancer Center, , Helsinki University Hospital and University of Helsinki, ; Helsinki, Finland
                [5 ]ISNI 0000 0004 1936 9756, GRID grid.10253.35, DataBionics Research Group, , University of Marburg, ; Hans – Meerwein - Straße, 35032 Marburg, Germany
                Author information
                http://orcid.org/0000-0002-5818-6958
                Article
                4841
                10.1007/s10549-018-4841-8
                6096884
                29876695
                7ad6f7d1-212b-484a-b690-87cb4105dc1b
                © The Author(s) 2018

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

                History
                : 21 December 2017
                : 29 May 2018
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100011102, Seventh Framework Programme;
                Award ID: 602919
                Award Recipient :
                Categories
                Clinical Trial
                Custom metadata
                © Springer Science+Business Media, LLC, part of Springer Nature 2018

                Oncology & Radiotherapy
                pain,bioinformatics,data science,chronification
                Oncology & Radiotherapy
                pain, bioinformatics, data science, chronification

                Comments

                Comment on this article